785
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Relationship between intra-operative vein graft treatment with DuraGraft® or saline and clinical outcomes after coronary artery bypass grafting

, , , , , , , & show all
Pages 963-970 | Received 23 Aug 2018, Accepted 02 Oct 2018, Published online: 14 Oct 2018

References

  • Neumann FJ, Sousa-Uva M, Ahlsson A, et al. ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2018 doi: 10.1093/eurheartj/ehy394. [Epub ahead of print].
  • Sousa-Uva M, Neumann FJ, Ahlsson A, et al. ESC/EACTS guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 2018. doi: 10.1093/ejcts/ezy289. [Epub ahead of print].
  • Alexander JH, Hafley G, Harrington RA, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294(19):2446–54.
  • de Vries MR, Simons KH, Jukema JW, et al. Vein graft failure: from pathophysiology to clinical outcomes. Nat Rev Cardiol. 2016;13(8):451–470.
  • Harskamp RE, Alexander JH, Schulte PJ, et al. Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial. JAMA Surg. 2014;149(8):798–805.
  • Goldman S, Sethi GK, Holman W, et al. Radial artery grafts vs saphenous vein grafts in coronary artery bypass surgery: a randomized trial. JAMA. 2011;305(2):167–174.
  • Harskamp RE, Lopes RD, Baisden CE, et al. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Ann Surg. 2013;257(5):824–833.
  • Harskamp RE, Williams JB, Hill RC, et al. Saphenous vein graft failure and clinical outcomes: toward a surrogate end point in patients following coronary artery bypass surgery? Am Heart J. 2013;165(5):639–643.
  • Kim FY, Marhefka G, Ruggiero NJ, et al. Saphenous vein graft disease: review of pathophysiology, prevention, and treatment. Cardiol Rev. 2013;21(2):101–109.
  • Thatte HS, Biswas KS, Najjar SF, et al. Multi-photon microscopic evaluation of saphenous vein endothelium and its preservation with a new solution, GALA. Ann Thorac Surg. 2003;75(4):1145–1152. discussion 1152.
  • Weiss DR, Juchem G, Kemkes BM, et al. Extensive deendothelialization and thrombogenicity in routinely prepared vein grafts for coronary bypass operations: facts and remedy. Int J Clin Exp Med. 2009;2(2):95–113.
  • Wilbring M, Tugtekin SM, Zatschler B, et al. Even short-time storage in physiological saline solution impairs endothelial vascular function of saphenous vein grafts. Eur J Cardiothorac Surg. 2011;40(4):811–815.
  • Wise ES, Hocking KM, Eagle S, et al. Preservation solution impacts physiologic function and cellular viability of human saphenous vein graft. Surgery. 2015;158(2):537–546.
  • Tsakok M, Montgomery-Taylor S, Tsakok T. Storage of saphenous vein grafts prior to coronary artery bypass grafting: is autologous whole blood more effective than saline in preserving graft function? Interact Cardiovasc Thorac Surg. 2012;15(4):720–725.
  • Winkler B, Reineke D, Heinisch PP, et al. Graft preservation solutions in cardiovascular surgery. Interact Cardiovasc Thorac Surg. 2016;23(2):300–309.
  • Williams JB, Harskamp RE, Bose S, et al. The preservation and handling of vein grafts in current surgical practice: findings of a survey among cardiovascular surgeons of top-ranked US Hospitals. JAMA Surg. 2015;150(7):681–683.
  • Thatte HS, Khuri SF. The coronary artery bypass conduit: I. Intraoperative endothelial injury and its implication on graft patency. Ann Thorac Surg. 2001;72(6): S2245–S2252. discussion S2267-70.
  • Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661–3679.
  • Lee BK, Lessler J, Stuart EA. Weight trimming and propensity score weighting. PLoS One. 2011;6(3):e18174.
  • Li FD, Eagle S, Brophy C, et al. Pressure control during preparation of saphenous veins. JAMA Surg. 2014;149(7):655–662.
  • Ben Ali W, Voisine P, Olsen PS, et al. DuraGraft vascular conduit preservation solution in patients undergoing coronary artery bypass grafting: rationale and design of a within-patient randomised multicentre trial. Open Heart. 2018;5(1):e000780.
  • Schoettler J, Jussli-Melchers J, Grothusen C, et al. Highly flexible nitinol mesh to encase aortocoronary saphenous vein grafts: first clinical experiences and angiographic results nine months postoperatively. Interact Cardiovasc Thorac Surg. 2011;13(4):396–400.
  • Taggart DP, Ben Gal Y, Lees B, et al. A randomized trial of external stenting for saphenous vein grafts in coronary artery bypass grafting. Ann Thorac Surg. 2015;99(6):2039–2045.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.